PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease

…, M Coleman, JP Leonard, I Kuji… - Journal of Nuclear …, 2002 - Soc Nuclear Med
Early identification of chemotherapy-refractory lymphoma patients provides a basis for
alternative treatment strategies. Metabolic imaging with 18 F-FDG PET offers functional tissue …

Comparison of fluorine‐18 fluorodeoxyglucose positron emission tomography and Ga‐67 scintigraphy in evaluation of lymphoma

L Kostakoglu, JP Leonard, I Kuji, M Coleman… - Cancer, 2002 - Wiley Online Library
BACKGROUND The accuracy of fluorodeoxyglucose positron emission tomography (FDG‐PET;
dual‐head camera with attenuation correction) and Ga‐67 scintigraphy was compared …

[HTML][HTML] Value of 18F-FDG-PET to predict PD-L1 expression and outcomes of PD-1 inhibition therapy in human cancers

K Kaira, I Kuji, H Kagamu - Cancer Imaging, 2021 - Springer
Anti-programmed cell death-1 (PD-1)/programmed death ligand-1 (PD-L1) antibodies are
administered in varied human cancer types. The expression of PD-L1 within tumor cells has …

[HTML][HTML] In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab

…, H Takeuchi, T Shigekawa, T Yamane, I Kuji… - British journal of …, 2016 - nature.com
Background: Eribulin mesylate (eribulin) is a first-in-class halichondrin B-based microtubule
dynamics inhibitor. To compare the anti-angiogenic activity of eribulin to that of bevacizumab…

[HTML][HTML] Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in …

I Kuji, T Yamane, A Seto, Y Yasumizu… - European Journal of …, 2017 - Springer
Purpose To investigate the improvement of prognostication of active bone metastatic burden
by discriminating bone metastases from degenerative changes in hot foci, using skeletal …

Bevacizumab induces acute hypoxia and cancer progression in patients with refractory breast cancer: multimodal functional imaging and multiplex cytokine analysis

S Ueda, T Saeki, A Osaki, T Yamane, I Kuji - Clinical Cancer Research, 2017 - AACR
Purpose: Bevacizumab, an antibody against endothelial growth factor, is a key but controversial
drug in the treatment of metastatic breast cancer. We, therefore, aimed to determine the …

[HTML][HTML] Potential of FDG-PET as prognostic significance after anti-PD-1 antibody against patients with previously treated non-small cell lung cancer

…, Y Murayama, K Kobayashi, H Kagamu, I Kuji - Journal of Clinical …, 2020 - mdpi.com
It remains unclear whether the accumulation of 2-deoxy-2-[ 18 F]fluoro-d-glucose ( 18 F-FDG)
before the initiation of anti-programmed death-1 (PD-1) antibody can predict the outcome …

Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma

I Kuji, E Imabayashi, A Minagawa, H Matsuda… - Annals of nuclear …, 2008 - Springer
We present an interesting case with a central mediastinal pheochromocytoma showing intense
F-18 fluorodeoxyglucose (FDG) uptake in tumor and systemic brown adipose tissue (BAT…

An easy Z-score imaging system for discrimination between very early Alzheimer's disease and controls using brain perfusion SPECT in a multicentre study

…, M Kimura, A Tateno, A Ishiwata, I Kuji… - Nuclear medicine …, 2007 - journals.lww.com
Methods Brain perfusion SPECT images of 40 Alzheimer's disease patients and 40 healthy
volunteers were acquired from four gamma camera systems in different institutions. …

Contribution of subtraction ictal SPECT coregistered to MRI to epilepsy surgery: a multicenter study

…, H Aiba, M Yano, YJ Kim, H Nakase, I Kuji… - Annals of nuclear …, 2009 - Springer
Objective A multicenter prospective study was performed to assess the additional value of a
subtraction ictal SPECT coregistered to MRI (SISCOM) technique to traditional side-by-side …